AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 50 filers reported holding AVROBIO INC in Q1 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $30,000 | +71.7% | 30,000 | +22.4% | 0.01% | +66.7% |
| Q4 2022 | $17,475 | +9.2% | 24,513 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $16,000 | -30.4% | 24,513 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $23,000 | +64.3% | 24,513 | +133.2% | 0.00% | +100.0% |
| Q1 2022 | $14,000 | -65.0% | 10,513 | 0.0% | 0.00% | -60.0% |
| Q4 2021 | $40,000 | -34.4% | 10,513 | -4.4% | 0.01% | -37.5% |
| Q3 2021 | $61,000 | – | 11,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 4,520,863 | $5,968,000 | 0.76% |
| Aisling Capital Management LP | 1,009,779 | $1,333,000 | 0.72% |
| MPM BioImpact LLC | 647,918 | $855,000 | 0.23% |
| GMT CAPITAL CORP | 2,594,914 | $3,425,000 | 0.22% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $417,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 338,422 | $447,000 | 0.06% |
| Penn Mutual Asset Management, LLC | 37,306 | $49,000 | 0.06% |
| Eversept Partners, LP | 295,369 | $389,887 | 0.03% |
| XTX Topco Ltd | 23,289 | $31,000 | 0.01% |
| Colonial River Wealth Management, LLC | 17,636 | $23,000 | 0.01% |